Programme/Approved Electives for 2025/26
None
Available as a Free Standing Elective
No
In recent years the emergence of personalized medicine and regenerative medicine therapies has driven a need for the associated advanced manufacturing capabilities. This module will introduce the fundamental requirements and regulation for current Good Manufacturing Practice (cGMP), supporting development of these specialized skill sets. This module will provide an understanding of current Good Manufacturing Processes (cGMP) for the biomanufacturing of advanced biological therapies, including the facility, process, quality, staffing, and regulatory compliance needs.The module will be delivered with a combination of lectures and workshop sessions.
Aims
This module will provide an understanding of current Good Manufacturing Processes (cGMP) for the biomanufacturing of advanced biological therapies, including the facility, process, quality, staffing, and regulatory compliance needs.
Intended Learning Outcomes
Identify the biomanufacturing needs for advanced therapies.: 2Critically analyse how regulatory standards and quality management processes contribute to product safety and efficacy.: 1,2Compare contrasting engineering solutions for achieving the required standards.: 2Formulate specific recommendations for improvements for identified examples where the required cGMP standards were not met.: 1Design a cGMP compliant solution, including limited supporting quality management documentation, for a theoretical/potential advanced biological therapy.: 2
Active Learning 10 x 1 hour lectures10x 2 hour workshops building on lecture content and supporting portfolio assessment1x2 hour tutorial on content/structure of the portfolio3 hour visit to Guy Hilton Cell Therapy suite4 hour visit to Charles River labs3 hour formative poster feedback sessionIndependent study hours to be spent:Further independent reading on the topics introduced in the lectures: 50 hoursPreparing your assessment 1 poster: 12 hoursWorking on your portfolio content: 46 hours
Description of Module Assessment
1: Poster weighted 30%Poster detailing recommendations to resolve failure to meet cGMP requirementsStudents will identify an example of bad practice from media sources where GMP requirements were not adhered to and will suggest modifications to cGMP procedures required to avoid this situation arising again. Students will produce an electronic poster covering the failure, the consequences and their proposed solution(s). A formative feedback opportunity including peer feedback will be offered.
2: Portfolio weighted 70%Portfolio covering aspects of the biomanufacturing requirements for a selected regenerative medicine technologyStudents will create a portfolio (max 3500 words) with sections reflecting each aspect of the manufacturing requirements for a selected regenerative medicine product. Sections will include identifying the regulatory status of the product, identifying material requirements, designing and identifying facility and engineering requirements, defining staffing requirements, processing, and specifying quality assurance/management processes including associated document examples. Supported with weekly tutorials related to the various sections, the portfolio will be submitted towards the end of the semester.